APA (7th ed.) Citation

Fang, J., Lou, S., Zhou, X., Lou, D., Zhou, L., & Bian, R. (2024). Dihydromyricetin reverses capecitabine‐induced peripheral myelin dysfunction through modulation of oxidative stress. Clinical & Experimental Pharmacology & Physiology, 51(3), 1. https://doi.org/10.1111/1440-1681.13833

Chicago Style (17th ed.) Citation

Fang, Jie, Shuyi Lou, Xinyi Zhou, Dayong Lou, Liqin Zhou, and Rong Bian. "Dihydromyricetin Reverses Capecitabine‐induced Peripheral Myelin Dysfunction Through Modulation of Oxidative Stress." Clinical & Experimental Pharmacology & Physiology 51, no. 3 (2024): 1. https://doi.org/10.1111/1440-1681.13833.

MLA (9th ed.) Citation

Fang, Jie, et al. "Dihydromyricetin Reverses Capecitabine‐induced Peripheral Myelin Dysfunction Through Modulation of Oxidative Stress." Clinical & Experimental Pharmacology & Physiology, vol. 51, no. 3, 2024, p. 1, https://doi.org/10.1111/1440-1681.13833.